Perinatal programming of metabolic diseases: role of insulin in the development of hypothalamic neurocircuits

Sophie M Steculorum1, Merly C Vogt, Jens C Brüning

  • 1Department of Mouse Genetics and Metabolism, University Hospital Cologne and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Köln 50674, Germany.

Insights

Maternal diabetes during development can program offspring for obesity and diabetes. Perinatal insulin and glucose levels permanently alter hypothalamic development, impacting long-term metabolic health in rodent models.

Area of Science:

  • Developmental biology
  • Metabolic regulation
  • Neuroendocrinology

Background:

  • Metabolic diseases like obesity and diabetes can be programmed during early development.
  • Offspring of diabetic mothers exhibit increased risk for metabolic dysfunction.
  • Perinatal metabolic environment significantly influences long-term health outcomes.

Purpose of the Study:

  • To review the regulatory roles of perinatal insulin and glucose on hypothalamic development.
  • To summarize findings on the long-term programming of metabolic diseases.
  • To highlight evidence from rodent models.

Main Methods:

  • Literature review of studies on rodent models.
  • Analysis of research on perinatal hyperinsulinemia and hyperglycemia.
  • Examination of hypothalamic network organization and function.

Main Results:

  • Perinatal metabolic disturbances permanently impair hypothalamic development.
  • Altered hypothalamic networks affect appetite and glucose homeostasis control.
  • Rodent models demonstrate a clear link between perinatal factors and metabolic disease programming.

Conclusions:

  • Perinatal insulin and glucose levels are critical regulators of hypothalamic development.
  • Early-life metabolic programming has lasting effects on metabolic health.
  • Rodent studies provide key insights into preventing metabolic diseases.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...